How HealthVerity ensures real-world data quality and privacy
(Part 1) When clients see real-world data (RWD) in HealthVerity Marketplace, it may appear...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
(Part 1) When clients see real-world data (RWD) in HealthVerity Marketplace, it may appear...
Electronic Health Records (EHR): What they are and how to use them in real-world data Electronic...
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
In this edition of our Ask an Expert series, we turn to Emery Niemiec, Senior Director,...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
Government health agencies are increasingly turning to real-world data (RWD) for public health...
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
AI is playing a growing role in real-world evidence, but not all AI serves the same purpose. Two terms often used interchangeably, Generative AI and Agentic AI, describe very different capabilities and the distinction matters in real-world evidence (...